» Articles » PMID: 30296891

A Third HSAN5 Mutation Disrupts the Nerve Growth Factor Furin Cleavage Site

Overview
Journal Mol Pain
Date 2018 Oct 10
PMID 30296891
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Bi-allelic dysfunctional mutations in nerve growth factor (NGF) cause the rare human phenotype hereditary sensory and autonomic neuropathy type 5 (HSAN5). We describe a novel NGF mutation in an individual with typical HSAN5 findings. The mutation c.361C>T, p.R121W is at the last residue of the furin cleavage motif Arg-Ser-Lys-Arg in proNGF. We show that the p.R121W mutation completely abolishes the formation of mature NGF-β. Surprisingly, mutant p.R121W cells produced very little proNGF. Instead, the two progressive cleavage products of proNGF were produced, proA-NGF and proB-NGF, with proB-NGF being the predominant NGF-derived peptide and the only peptide secreted by mutant p.R121W cells. We found that the ability of the p.R121W mutation to cause tropomyosin receptor kinase A autophosphorylation and mitogen-activated protein kinase phosphorylation was significantly reduced compared to controls (p < 0.05 and p < 0.01). By studying the PC12 cell line morphology and neurite length over a week, we found the p.R121W mutation had residual, but much reduced, neurotrophic activity when compared to wild-type NGF. Finally, we assessed whether the p.R121W mutation affected apoptosis and found a reduced protective effect compared to wild-type NGF. Our results suggest that the p.R121W NGF mutation causes HSAN5 through negating the ability of furin to cleave proNGF to produce NGF-β.

Citing Articles

Genetic landscape of congenital insensitivity to pain and hereditary sensory and autonomic neuropathies.

Lischka A, Eggermann K, Record C, Dohrn M, Lassuthova P, Kraft F Brain. 2023; 146(12):4880-4890.

PMID: 37769650 PMC: 10689924. DOI: 10.1093/brain/awad328.


Genetic pain loss disorders.

Lischka A, Lassuthova P, Cakar A, Record C, Van Lent J, Baets J Nat Rev Dis Primers. 2022; 8(1):41.

PMID: 35710757 DOI: 10.1038/s41572-022-00365-7.


The development of somatosensory neurons: Insights into pain and itch.

Cranfill S, Luo W Curr Top Dev Biol. 2021; 142:443-475.

PMID: 33706924 PMC: 8099032. DOI: 10.1016/bs.ctdb.2020.10.005.


Understanding the genetic basis of congenital insensitivity to pain.

Drissi I, Woods W, Woods C Br Med Bull. 2020; 133(1):65-78.

PMID: 32219415 PMC: 7227775. DOI: 10.1093/bmb/ldaa003.


Nerve growth factor-mediated photoablation of nociceptors reduces pain behavior in mice.

Nocchi L, Portulano C, Franciosa F, Doleschall B, Panea M, Roy N Pain. 2019; 160(10):2305-2315.

PMID: 31365468 PMC: 6756257. DOI: 10.1097/j.pain.0000000000001620.

References
1.
Einarsdottir E, Carlsson A, Minde J, Toolanen G, Svensson O, Solders G . A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet. 2004; 13(8):799-805. DOI: 10.1093/hmg/ddh096. View

2.
Nahorski M, Al-Gazali L, Hertecant J, Owen D, Borner G, Chen Y . A novel disorder reveals clathrin heavy chain-22 is essential for human pain and touch development. Brain. 2015; 138(Pt 8):2147-60. PMC: 4511860. DOI: 10.1093/brain/awv149. View

3.
Minde J, Andersson T, Fulford M, Aguirre M, Nennesmo I, Remahl I . A novel NGFB point mutation: a phenotype study of heterozygous patients. J Neurol Neurosurg Psychiatry. 2008; 80(2):188-95. DOI: 10.1136/jnnp.2007.136051. View

4.
Pagadala P, Dvorak L, Neet K . Construction of a mutated pro-nerve growth factor resistant to degradation and suitable for biophysical and cellular utilization. Proc Natl Acad Sci U S A. 2006; 103(47):17939-43. PMC: 1693851. DOI: 10.1073/pnas.0604139103. View

5.
Hepburn L, Prajsnar T, Klapholz C, Moreno P, Loynes C, Ogryzko N . Innate immunity. A Spaetzle-like role for nerve growth factor β in vertebrate immunity to Staphylococcus aureus. Science. 2014; 346(6209):641-646. PMC: 4255479. DOI: 10.1126/science.1258705. View